INTRODUCTION. Key Words: Helicobacter pylori; Gastric cancer; Cyclooxygenase 2
|
|
- Brittney Rice
- 5 years ago
- Views:
Transcription
1 The Korean Journal of Helicobacter and Upper Gastrointestinal Research Vol. 11, No. 2, , September 2011 Helicobacter pylori Eradication Suppresses Metachronous Gastric Cancer and Cyclooxygenase-2 Expression after Endoscopic Resection of Early Gastric Cancer Background/Aims: The impact of Helicobacter pylori (H. pylori) eradication after endoscopic resection (ER) of early gastric cancer (EGC) has not been fully evaluated. We tried to find out the effect of H. pylori eradication therapy on the development of metachronous gastric cancers and changes in Cyclooxygenase-2 (COX-2) expression following attempts to eradicate H. pylori after ER of EGC. Materials and Methods: We eradicated H. pylori in the patients with EGC after ER. Biopsy samples were taken according to the follow-up schedules for surveillance after ER. Results: Fifty five patients were enrolled and finished the follow up schedules. Of the 55, 28 were successfully treated H. pylori infection, and the other 27 were failed eradication of H. pylori. The mean follow-up period was 60.8 months. Five in the H. pylori ongoing infection group developed metachronous gastric cancer, whereas no new gastric cancers were found in the 28 eradication group (P=0.023). COX-2 expression in the eradication group was significantly decreased (1.4±0.2, n=28), compared to that in H. pylori ongoing infection group (3.0±0.4, n=27, P=0.0001) after the follow-up. Conclusions: The eradication of H. pylori seems to have a preventative effect on the development of metachronous adenocarcinomas and a suppressive effect on COX-2 expression in the patients after ER for EGC. (Korean J Helicobacter Upper Gastrointest Res 2011;11: ) Key Words: Helicobacter pylori; Gastric cancer; Cyclooxygenase 2 Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea Hwa Jong Kim, Su Jin Hong, Bong Min Ko, Won Young Cho, Joo Young Cho, Joon Seong Lee, Moon Sung Lee Received:April 30, 2011 Accepted:May 29, 2011 Corresponding author: Su Jin Hong Department of Internal Medicine, Soonchunhyang University College of Medicine, 1174, Jung-dong, Wonmi-gu, Bucheon , Korea Tel: Fax: sjhong@schmc.ac.kr INTRODUCTION Despite its decreasing incidence over recent decades, gastric cancer is still the second leading cause of cancer-related deaths worldwide. 1 The development and progression of gastric cancer seem to result, in part, from the accumulation of multiple genetic alterations, which lead to oncogene overexpression and tumor suppressor loss. 2,3 The most important single factor responsible for the development of gastric cancer is Helicobacter pylori (H. pylori) infection, which affects more than 50% of the world s population. 4 The risk for developing gastric cancer in patients with H. pylori infection is about two- to six-fold increases in non-infection individuals, according to epidemiological studies. 5-7 When diagnosed at an advanced stage, gastric cancer is usually an incurable disease. However, resection of the tumor at an early stage can confer a relatively favorable prognosis. Complete cures have been obtained in some early gastric cancers (EGC), especially with the use of endoscopic treatment modalities such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). 8,9 The incidence of lymph node metastasis is 0.36% in mucosal gastric cancer patients who have no lymphatic invasion, no histological ulceration, and a tumor diameter of less than 30 mm. 10 After endoscopic resection (ER), the disease can recur in the stomach in two patterns, local recurrence or metachronous gastric cancers. Many metachronous gastric cancers are thought to be de novo cancers and may arise from the same high-risk background mucosa. The relationship between metachronous recurrence and H. 117
2 118 The Korean Journal of Helicobacter and Upper Gastrointestinal Research: 제 11 권제 2 호 2011 pylori infection remains controversial. Arima et al. 11 reported that H. pylori infection showed no significant relationship with metachronous recurrence. However, others have observed that H. pylori eradication inhibited the development of metachronous carcinoma in the remnant stomach. 12,13 Cyclooxygenase-2 (COX-2) is a rate-limiting enzyme in prostaglandin synthesis from arachidonic acid. COX-2 expression is thought to be a relatively early event during gastric carcinogenesis. Previous studies have demonstrated increased COX-2 expression in both H. pylori-related gastritis and gastric adenocarcinomas COX-2 expression is increased in intestinal-type gastric cancers and in the crypts with intestinal metaplasia. 18 Relatives of gastric cancer patients showed higher gastric COX-2 expression and higher incidence of precancerous lesions after H. pylori infection than did relatives of H. pylori-infected patients with duodenal ulcers. 19 Furthermore, patients with intestinal-type adenocarcinomas had frequent atrophy and intestinal metaplasia in the surrounding gastric mucosa, compared to patients with diffuse-type adenocarcinoma, gastric lymphoma, or no neoplasia. 20 H. pylori infection resulted in overexpression of COX-2 that was reversed by H. pylori eradication. 21,22 Therefore, eradication therapy may reduce the risk of gastric cancer development. Given this information, we sought to assess the effects of H. pylori eradication on the development of new gastric cancers in patients who underwent endoscopic resection to treat early gastric cancer and on the expression of COX-2. MATERIALS AND METHODS 1. Patients The study was enrolled a total of 55 consecutive patients with H. pylori infection (36 males, 19 females; mean, age 60.7 years) who had received successful ER for EGC between March 2001 and November 2003 and follow-up for more than 24 months at Bucheon Hospital, Soonchunhyang University, Korea. Patients taking aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, bismuth preparations, or proton pump inhibitors during the month before the examination were excluded from the study. All patients provided informed consent about histological analysis and preserve of H. pylori status after primary eradication therapy for H. pylori. 2. Study design Biopsy samples were taken from the cancer, the adjacent non-cancerous area, and two additional areas (two samples from the antrum, within 2 cm of the pyloric channel, and two from the corpus) before the EMR procedure. All gastric specimens were fixed in 10% buffered formalin for H&E staining or COX-2 immunostaining. The presence of H. pylori was determined by a CLO test (Delta West Ltd., Perth, Australia) and a 13 C-urea breath test. Patients with EGC were considered suitable candidates for endoscopic resection at our institution if they met all of the following criteria: clinical findings of intramucosal adenocarcinoma, differentiated-type adenocarcinoma, protruding-type or superficial elevated type no more than 3 cm in diameter, or superficial depressed type no more than 2 cm in diameter; no ulceration in the cancer; and no evidence of lymph node or distant metastases. Endoscopic resection was performed using conventional EMR or endoscopic submucosal dissection. After the endoscopic resection procedure, all patients were attempted to treat for H. pylori infection using proton pump inhibitors based triple therapy. Endoscopic follow-up with biopsies was performed on each patient at 3, 12, 24, 36, 48, 60, and 72 months after ER. In addition, in patients with upper gastrointestinal system symptoms, we performed esophagogastroduodenoscopy at that time. We looked for any metachronous gastric cancer and cancer relapse, and collected gastric biopsy specimens for histological examination and COX-2 immunostaining. Each patient underwent a CLO test and a 13 C-urea breath test to determine H. pylori status, with endoscopic surveillance. 3. Immunohistochemistry for COX-2 A paraffin-embedded mucosal biopsy specimen was mounted on a silane-coated glass slide. Immunohistochemical staining was performed using antibodies specific for COX-2; the COX2 antibody was a monoclonal antibody raised in a mouse against a synthetic peptide corresponding to human COX-2, amino acids (DAKO, Carpinteria, CA, USA). For immunostaining, the COX-2 antibody (diluted 1:100) was incubated with the sections for 1 h at 37 o C, using a microwave method. The primary antibody was omitted as a negative control. The immunoreactivity was recorded using semi-quantitative and subjective grading, considering both the intensity of staining and the number of immunoreactive cells. The intensity was
3 Hwa Jong Kim, et al:h. pylori Eradication and Metachronous Gastric Cancer 119 recorded as 0 (no staining) to 3 (strong staining), using fundic glandular cells as controls. Positive reactions similar to those in the control cells were scored as 2 (moderate staining). Tissue specimens showing significantly more intense staining than the control cells were scored as 3 (strong staining), specimens with a readily noticeable reduction in staining intensity were scored as 1 (weak staining), and specimens with undetectable or negligible expression were scored as 0 (no staining). The staining area, defined as the total amount of positively staining cells, was recorded as 0 (none or positive staining in <5% of the cells), 1 (positive staining in 5 30%), 2 (positive staining in 31 60%), or 3 (positive staining in >60%). The staining index, which ranged from 0 to 9, was obtained by multiplying the score for staining intensity times the staining area. 4. Statistical analysis All results are expressed as means±sem. For statistical analysis, ANOVA single-factor analysis was performed. Differences were deemed significant when P<0.05. The incidence of cancer in other regions was compared between the two groups using the χ 2 test and Student s t-test. All statistical computations were performed using SPSS v.10 (SPSS Inc., Chicago, IL, USA). RESULTS Table 1 shows the characteristics of the 55 patients. The mean follow-up period of the patients was 60.8 months. A total of 55 patients with H. pylori infection (36 males, 19 females; mean age, 60.7 years) who underwent successful ER for EGC and were followed up. Of the 55, 28 were successfully treated with triple therapy for H. pylori infection, and the other 27 were failed eradication of H. pylori or couldn t take those medications by poor compliance or side effects. There was no significant difference in any demographic characteristic between the groups. During the endoscopic follow up period, no newly developed cancers were observed in the eradication group. However, metachronous gastric cancers were detected in other regions in five patients (18.5%) belonging to the ongoing in- Table 1. Characteristics of the Patients Ongoing Eradication Variable infection P value group group Number NS Age a (years) 62 (43 80) 60 (45 81) NS Gender (male/female) 19/10 17/9 NS Depth of EGC (m1//m3) 3/20/5 3/17/7 NS Mean size of EGC (mm) NS Site (antrum/angle/corpus) 14/4/10 15/5/7 NS NS, not significant. a Mean (range). Fig. 1. A Kaplan-Meier plot shows the proportion of patients free of metachronous cancer after eradication therapy for H. pylori. Table 2. Demographic Features of Patients with Metachronous Gastric Cancer Age (yr) Gender Time to 2 nd cancer (months) Depth of 2 nd cancer Size of 2 nd cancer Location 1 st cancer 2 nd cancer Male Male Male Female Female m cm cm cm cm cm Corpus Angle
4 120 The Korean Journal of Helicobacter and Upper Gastrointestinal Research: 제 11 권제 2 호 2011 fection group; this was significantly higher than the occurrence in the eradication group (P=0.023, χ 2 test, Fig. 1). The metachronous gastric cancers were found in the five patients within 4 years of ER: two at months, two at 36 months, and one at 48 months after ER. Each metachronous gastric cancer was less than 10 mm in size and was located in the mucosal layer (Table 2). In the eradication group, we analyzed the grade of gastritis in the pre-eradication period and that of last follow-up biopsies after H. pylori eradication. The neutrophil infiltration scores in the antrum and the corpus were markedly decreased (antrum: 1.1±0.1, corpus: 1.4±0.1), compared to the scores in the pretreatment period (antrum: 1.7±0.2, corpus: 2.3±0.1, P<0.01). The atrophy score declined from 1.9±0.1 to 1.6±0.1 (P=0.030) in the corpus and from 2.0±0.2 to 1.6±0.1 in the antrum (P=0.048) after H. pylori eradication. Furthermore, the grade of intestinal metaplasia (IM) in the corpus significantly decreased, from 1.9±0.2 to 1.6±0.2 (P=0.043). Slightly increased COX-2 expression was found in the cancer tissues (4.5±0.5), compared to their respective paired H. pylori-infected normal adjacent mucosa (3.2±0.3), but the difference was not statistically significant (P=0.07). There was no difference in COX-2 immunoreactivity in the mucosa adjacent to cancer tissues between the groups before EMR therapy (3.3±0.3 versus 3.0±0.4, P=0.914). However, COX-2 expression in adjacent mucosa in the eradication group was significantly decreased (1.4±0.2), compared to that in the ongoing infection group (3.0±0.4, P=0.0001), at the last follow-up (Fig. 2, 3). COX-2 expression of the mucosa adjacent to cancer tissue was high in the patients with metachronous gastric cancer compared to that in the patients without metachronous cancer of ongoing infection group (5.6±0.9 versus 2.5±2.0, P=0.003). DISCUSSION Fig. 2. COX-2 expression in the mucosa adjacent to the cancer. COX-2 expression in the adjacent mucosa was significantly lower in the eradication group than in the ongoing infection group at the last follow-up. The intestinal type of gastric adenocarcinoma forms glandular structures that somewhat resemble the glands of the gastrointestinal tract. This type has glandular atrophy with IM in the background mucosa. 23 The second histological type, the diffuse carcinoma, invades the organ without forming well-defined Fig. 3. Immunohistochemical staining for COX-2. (A) COX-2 expression is present in epithelial cells and inflammatory mononuclear cells of patients after endoscopic resection for early gastric cancer and before eradication of H. pylori (original magnification, 100). (B) COX-2 expression significantly decreased after eradication of H. pylori (original magnification, 100).
5 Hwa Jong Kim, et al:h. pylori Eradication and Metachronous Gastric Cancer 121 structures such as glands. No clear precancerous lesions have been identified for the diffuse type. The diffuse type of gastric adenocarcinoma has different features and characteristics from the intestinal type. 24,25 Furthermore, a diffuse histotype has been related to earlier presences of lymph node metastases. An absolute indication for ER of EGC can be considered the intestinal type of intramucosal cancer. Accordingly, patients with ER therapy for EGC retain potentially carcinogenic mucosa, which can develop into overt gastric adenocarcinoma at any time. COX-2, an inducible isoform of cyclooxygenase enzyme, converts arachidonic acid to prostanoids and is strongly expressed throughout the H. pylori-associated gastric carcinogenesis pathway, from chronic active gastritis, to gastric atrophy and IM, and finally to gastric adenocarcinoma. 19,20 All our subjects had carcinogenic mucosa and H. pylori infection, and COX-2 expression was demonstrated in their epithelium. The expression of COX-2 in the eradication group was significantly decreased after H. pylori eradication. However, the ongoing infection group revealed continuous, strong expression of COX-2 in our study. Mucosal COX-2 expression has been shown to continue in patients with IM, even after eradication of H. pylori infection. 26 Other investigators have found that patients with IM exhibited reduced COX-2 expression at 1 year after successful H. pylori eradication, compared to expression before eradication therapy. 27 Our results are consistent with the latter observation. Our cancer patients with high carcinogenic background mucosa, including IM, showed decreased carcinogenic potential of the mucosa at more than 3 years after H. pylori eradication. This is based on decreased COX2 expression and the regression of atrophy and corporal IM in our patients after H. pylori eradication. Furthermore, newly developed metachronous early gastric cancers were detected only in the ongoing infection group. Some studies have suggested that the suppression of COX-2 reduced tumor development Methods of suppressing COX-2 in gastric mucosa include the ingestion of probiotics and H. pylori eradication therapy for H. pylori-infected mucosa, in addition to COX-2 inhibitors. 20 However, the ability of these methods to actually suppress the incidence of gastric cancer development in high-risk patients remains controversial. Helicobacter pylori infection plays an important role in gastric carcinogenesis, but the mechanism of COX-2 expression in H. pylori-related carcinogenesis is still unclear. Several studies have suggested that genetic polymorphisms in COX-2 are associated with risk for colorectal, lung, bladder, and gastric cancers Subjects with the 1195 AA genotype had increased risk for gastric cancer, and an additionally elevated risk for gastric cancer was observed in subjects exhibiting the AA genotype and H. pylori infection or smoking. 34 Subjects with the 1195 AA genotype also had high COX-2 expression, compared to subjects with the 1195 GG genotype. This genetic variation leads to differences in the metabolism of NSAIDs, in prostaglandin synthesis, and in individual cancer risk. Although we did not evaluate COX-2 genotypes, we believe that the elimination of H. pylori blocked over-expression of COX-2 and suppressed metachronous gastric cancer in our patients who were at high risk for gastric adenocarcinoma. The eradication rate of this study was 50.9% by intention-to-treat analysis. Hwang, et al. showed that the eradication rate of H. pylori depends on the antibiotic resistance. 35 In the study, the overall eradication rate of PPI triple therapy was 63.6% by intention-to-treat analysis. Our study also included the patients who did not complete the medicines for H. pylori eradication on account of poor compliance or side effects. We also assumed that a lot of the patients with antibiotic resistance were enrolled in the study. We found 5 patients with metachronous gastric cancer in the ongoing infection group. The rate of the metachronous gastric cancer was relatively high compared to previous study in Japan. 13 Most of previous studies were performed during only 3 years after ER. 13,36 Three metachronous cancers of our study were observed at 36 months and 48 months after ER. Fukase s study showed that 167 patients of control group could be followed up at 3 years. The cumulative incidence of metachronous gastric cancer was 14.4% among the 167 patients. The cumulative incidence rate of the study is very similar to the rate of our study at 3 years after ER. Limitations of our study include the involvement a relatively small number of patients. A randomized multicenter trial assessing the preventive effect of H. pylori eradication on occurrence of new gastric carcinomas after ER was published in Japan. 36 However, the results of this Japanese study showed a relatively short-term outcome during 3 years. In our study, we observed long-term suppression of the development of metachronous gastric adenocarcinomas and decreased COX-2 expression after H. pylori eradication therapy in the patients who underwent ER of EGC. Further studies on a larger scale may confirm the usefulness of H. pylori eradication therapy in these
6 122 The Korean Journal of Helicobacter and Upper Gastrointestinal Research: 제 11 권제 2 호 2011 patients. REFERENCES 1. Nardone G. Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 2003;17(Suppl 2): Stock M, Otto F. Gene deregulation in gastric cancer. Gene 2005; 360: Choi IS, Wu TT. Epigenetic alterations in gastric carcinogenesis. Cell Res 2005;15: Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13: Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114: Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999;94: Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49: Onozato Y, Ishihara H, Iizuka H, et al. Endoscopic submucosal dissection for early gastric cancers and large flat adenomas. Endoscopy 2006;38: Imagawa A, Okada H, Kawahara Y, et al. Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy 2006;38: Yamao T, Shirao K, Ono H, et al. Risk factors for lymph node metastasis from intramucosal gastriccarcinoma. Cancer 1996;77: Arima N, Adachi K, Katsube T, et al. Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J Clin Gastroenterol 1999l;29: Hamaguchi K, Ogawa K, Katsube T, Konno S, Aiba M. Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbecks Arch Surg 2004;389: Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6: Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57: Uefuji K, Ichikura T, Mochizuki H, Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol 1998;69: McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999;94: Wambura C, Aoyama N, Shirasaka D, et al. Effect of Helicobacte rpylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics: implication for gastric carcinogenesis. Helicobacter 2002;7: Yamagata R, Shimoyama T, Fukuda S, Yoshimura T, Tanaka M, Munakata A. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol 2002;14: Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res 2003;9: Arista-Nasr J, Jiménez-Rosas F, Uribe-Uribe N, Herrera-Goepfert R, Lazos-Ochoa M. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas. Am J Gastroenterol 2001;96: Brzozowski T, Konturek PC, Mierzwa M, et al. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils. Helicobacter 2006;11: Wambura C, Aoyama N, Shirasaka D, et al. Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2004; 16: Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52: Hong SJ, Kwon KW, Kim SG, et al. Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma. Cytokine 2006;33: Nomura S, Nakajima A, Ishimine S, Matsuhashi N, Kadowaki T, Kaminishi M. Differential expression of peroxisome proliferatoractivated receptor in histologically different human gastric cancer tissues. J Exp Clin Cancer Res 2006;25: Kimura A, Tsuji S, Tsujii M, et al. Expression of cyclooxygenase-2 and nitrotyrosine in human gastric mucosa before and after Helicobacter pylori eradication. Prostaglandins Leukot Essent Fatty Acids 2000;63: Sung JJ, Leung WK, Go MY, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000;157: Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87: Chen JH, Wu CW, Kao HL, et al. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Cancer Lett 2006;239: Nam KT, Hahm KB, Oh SY, et al. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 2004; 10: Cox DG, Pontes C, Guino E, et al. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of
7 Hwa Jong Kim, et al:h. pylori Eradication and Metachronous Gastric Cancer 123 colorectal cancer. Br J Cancer 2004;91: Hu Z, Miao X, Ma H, et al. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 2005; 48: Kang S, Kim YB, Kim MH, et al. Polymorphism in the nuclear factor kappa-b binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. Cancer Lett 2005;217: Liu F, Pan K, Zhang X, et al. Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 2006;130: Hwang TJ, Kim N, Kim HB, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rrna on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 2010;44: Fukase K, Kato M, Kikuchi S, et al.; Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:
Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia
E311 before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia Authors Institution Masaaki Kodama, Tadayoshi Okimoto, Ryo Ogawa, Kazuhiro Mizukami,
More informationLong-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
Gut and Liver, Vol. 12, No. 2, March 218, pp. 133-141 ORiginal Article Long-Term ffects of Helicobacter pylori radication on Metachronous Gastric Cancer Development Seung Jun Han 1, Sang Gyun Kim 1, Joo
More informationDisclosures. Gastric Intestinal Metaplasia and Early Gastric Cancer: Screening, Surveillance, and Endoscopic Therapy. ASGE Guidelines.
Gastric Intestinal Metaplasia and Early Gastric Cancer: Screening, Surveillance, and Endoscopic Therapy Consultant for: Olympus Medtronic US Endoscopy Disclosures Joo Ha Hwang, MD, PhD Associate Professor
More informationEffect of Helicobacter pylori Eradication on Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasm
60 ORIGINAL CONTRIBUTIONS nature publishing group see related editorial on page x Effect of Helicobacter pylori Eradication on Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasm Suh
More informationSonic hedgehog expression in gastric cancer and gastric adenoma
ONCOLOGY REPORTS 17: 1051-1055, 2007 Sonic hedgehog expression in gastric cancer and gastric adenoma SUN-YOUNG LEE 1, HYE SEUNG HAN 2, KYUNG YUNG LEE 3, TAE SOOK HWANG 2, JEONG HWAN KIM 1, IN-KYUNG SUNG
More informationESD for EGC with undifferentiated histology
ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>
More informationCyclooxygenase-2 Expression in Gastric Antral Mucosa Before and After Eradication of Helicobacter pylori Infection
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 94, No. 5, 1999 1999 by Am. Coll. of Gastroenterology ISSN 0002-9270/99/$20.00 Published by Elsevier Science Inc. PII S0002-9270(99)00126-4 Cyclooxygenase-2
More informationTreatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea
Treatment Strategy for Non-curative Resection of Early Gastric Cancer Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Classic EMR/ESD data analysis style Endoscopic resection
More informationPrognostic analysis of gastric mucosal dysplasia after endoscopic resection: A single-center retrospective study
JBUON 2019; 24(2): 679-685 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Prognostic analysis of gastric mucosal dysplasia after endoscopic resection:
More informationCurrent status of gastric ESD in Korea. Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea
Current status of gastric ESD in Korea Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea Contents Brief history of gastric ESD in Korea ESD/EMR for gastric adenoma
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400
More informationCASE REPORT. Introduction. Case Report. Kimitoshi Kubo 1, Noriko Kimura 2, Katsuhiro Mabe 1, Yusuke Nishimura 1 and Mototsugu Kato 1
doi: 10.2169/internalmedicine.0842-18 Intern Med 57: 2951-2955, 2018 http://internmed.jp CASE REPORT Synchronous Triple Gastric Cancer Incorporating Mixed Adenocarcinoma and Neuroendocrine Tumor Completely
More informationJi Hyuk Kang, Yun Jeong Lim, Jung Hyun Kang, Jae Nam Yang, Seung Min Shin, Jae Hyeuk Choi, and Jin Ho Lee
Gastroenterology Research and Practice Volume 2015, Article ID 571965, 5 pages http://dx.doi.org/10.1155/2015/571965 Research Article Prevalence of Precancerous Conditions and Gastric Cancer Based upon
More informationHelicobacter pylori Improved Detection of Helicobacter pylori
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.4.2099 RESEARCH ARTICLE Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using Conventional White Light Source Gastroscopy
More informationHelicobacter pylori Eradication in Patients with an Iatrogenic Ulcer after Endoscopic Resection and Peptic Ulcer
ORIGINAL ARTICLE ISSN 1738-3331, https://doi.org/10.7704/kjhugr.2018.18.1.30 The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2018;18(1):30-37 Helicobacter pylori Eradication in
More informationRisk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer
498 Original article Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer Authors C. Kunisaki 1, M. Takahashi 2, Y. Nagahori 3, T. Fukushima 3, H. Makino
More information헬리코박터파일로리감염에서고용량및다빈도덱스란소프라졸과아모시실린이중치료 : 단일군전향연구
Korean J Gastroenterol Vol. 70 No. 4, 176-180 https://doi.org/10.4166/kjg.2017.70.4.176 pissn 1598-9992 eissn 2233-6869 ORIGINAL ARTICLE 헬리코박터파일로리감염에서고용량및다빈도덱스란소프라졸과아모시실린이중치료 : 단일군전향연구 박혜윤, 강은정, 김동근, 김기주,
More informationHow to treat early gastric cancer? Endoscopy
How to treat early gastric cancer? Endoscopy Presented by Pierre H. Deprez Institution Cliniques universitaires Saint-Luc, Brussels Université catholique de Louvain 2 3 4 5 6 Background Diagnostic or therapeutic
More informationAssociation of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia
ADVANCES IN BIORESEARCH Adv. Biores., Vol 8 [3] May 2017: 137-141 2017 Society of Education, India Print ISSN 0976-4585; Online ISSN 2277-1573 Journal s URL:http://www.soeagra.com/abr.html CODEN: ABRDC3
More informationHelicobacter and gastritis
1 Helicobacter and gastritis Dr. Hala Al Daghistani Helicobacter pylori is a spiral-shaped gram-negative rod. H. pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric ulcers,
More informationThe detection rate of early gastric cancer has been increasing owing to advances in
Focused Issue of This Month Sung Hoon Noh, MD, ph.d Department of Surgery, Yonsei University College of Medicine E - mail : sunghoonn@yuhs.ac J Korean Med Assoc 2010; 53(4): 306-310 Abstract The detection
More informationClinical Outcomes of Endoscopic Submucosal Dissection in Patients under 40 Years Old with Early Gastric Cancer
ORIGINAL ARTICLE ISSN 1738-3331, http://dx.doi.org/10.7704/kjhugr.2016.16.3.139 The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2016;16(3):139-146 Clinical Outcomes of Endoscopic
More informationResearch Article Characteristics of Metachronous Gastric Tumors after Endoscopic Submucosal Dissection for Gastric Intraepithelial Neoplasms
Gastroenterology Research and Practice, Article ID 863595, 6 pages http://dx.doi.org/1.1155/214/863595 Research Article Characteristics of Metachronous Gastric Tumors after Endoscopic Submucosal Dissection
More informationEffect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer
pissn 1598-2998, eissn 25-9256 Cancer Res Treat. 216;48(3):12-129 Original Article http://dx.doi.org/1.4143/crt.215.264 Open Access Effect of Helicobacter pylori Eradication on Long-Term Survival after
More informationDelayed Perforation Occurring after Endoscopic Submucosal Dissection for Early Gastric Cancer
CASE REPORT Clin Endosc 2015;48:251-255 Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.3.251 Open Access Delayed Perforation Occurring after Endoscopic Submucosal Dissection
More information위암내시경진단 (2019) - 융기형위암을중심으로 성균관대학교의과대학내과이준행
위암내시경진단 (2019) - 융기형위암을중심으로 성균관대학교의과대학내과이준행 위암내시경진단 (2019) 위암검진에대한짧지않은 comment 융기형암은융기되어있는가? 함몰형암은함몰되어있는가? Semi-pedunculated polyp Sentinel polyp or EGJ cancer? IIa + IIc 위암검진에대한짧지않은 comment 성균관대학교의과대학내과이준행
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationThe effect of proton pump inhibitors on the gastric mucosal microenvironment
Original papers The effect of proton pump inhibitors on the gastric mucosal microenvironment Yen-Chun Peng,,, A F, Lan-Ru Huang, A, C, E, Hui-Ching Ho, C, Chi-Sen Chang, C, E, Shou-Wu Lee, E, Ching-Chang
More informationHistopathology of Endoscopic Resection Specimens from Barrett's Esophagus
Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus Br J Surg 38 oct. 1950 Definition of Barrett's esophagus A change in the esophageal epithelium of any length that can be recognized
More informationA case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer
Gastric Cancer (2015) 18:188 192 DOI 10.1007/s10120-014-0341-7 CASE REPORT A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer
More informationCOMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,
More informationHelicobacter pylori: Diagnosis, treatment and risks of untreated infection
Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb
More informationComparison of the Diagnostic Usefulness of Conventional Magnification and Near-focus Methods with Narrow-band Imaging for Gastric Epithelial Tumors
ORIGINAL ARTICLE ISSN 1738-3331, http://dx.doi.org/10.7704/kjhugr.2015.15.1.39 The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2015;15(1):39-43 Comparison of the Diagnostic Usefulness
More informationRegression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori
Gut and Liver, Vol. 6, No. 2, April 2012, pp. 270-274 CASE REPORT Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori Soo-Kyung Park, Hwoon-Yong Jung, Do Hoon Kim,
More informationCase Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination
Hindawi Publishing Corporation Case Reports in Medicine Volume 2015, Article ID 479625, 5 pages http://dx.doi.org/10.1155/2015/479625 Case Report Intramucosal Signet Ring Cell Gastric Cancer Diagnosed
More informationBarrett s Esophagus: Old Dog, New Tricks
Barrett s Esophagus: Old Dog, New Tricks Stuart Jon Spechler, M.D. Chief, Division of Gastroenterology, VA North Texas Healthcare System; Co-Director, Esophageal Diseases Center, Professor of Medicine,
More informationOriginal Policy Date
MP 2.04.38 Genetic Testing for Helicobacter pylori Treatment Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return
More informationEarly Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease
GASTROENTEROLOGY 2009;137:1641 1648 Early Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease CHUN YING WU,*,, KEN N. KUO, MING SHIANG WU, YI JU CHEN,,#
More informationEndoscopic Submucosal Dissection ESD
Endoscopic Submucosal Dissection ESD Peter Draganov MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida Gastrointestinal Cancer Lesion that Can be Treated
More informationGastroenterology Tutorial
Gastroenterology Tutorial Gastritis Poorly defined term that refers to inflammation of the stomach. Infection with H. pylori is the most common cause of gastritis. Most patients remain asymptomatic Some
More informationRisk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy
Gut and Liver, Vol. 11, No. 5, September 2017, pp. 612-619 ORiginal Article Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy Ji Hyun Song 1, Sang Gyun Kim 2, Eun Hyo Jin 1,
More informationBarrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI
Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine
More informationDepartmental and institutional affiliation: Departments of Medicine, Samsung Medical
Endoscopic Submucosal Dissection for Early Gastric Neoplasia Occurring in the Remnant Stomach after Distal Gastrectomy Short running title: ESD for tumors in the remnant stomach Authors: Ji Young Lee,
More informationKorean gastric cancer screening program, algorithms and experience.
Korean gastric cancer screening program, algorithms and experience. Jun Haeng Lee, MD. Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea Today s topics Korean cancer screening
More informationClinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma
Original Article Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma Zhaode Bu, Zhixue Zheng, Ziyu Li, Xiaojiang Wu, Lianhai Zhang, Aiwen Wu,
More informationAbstract. Background. Aims. Methods. Results
RESEARCH ARTICLE Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis Da Hyun Jung 1, Jie-Hyun Kim 2, Hyun Soo Chung
More informationLong-term survival after endoscopic resection versus surgery in early gastric cancers
Original article 293 Long-term survival after endoscopic versus surgery in early gastric cancers Authors Institution submitted 21. April 214 accepted after revision 27. October 214 Bibliography DOI http://dx.doi.org/
More informationThe New England Journal of Medicine. Patients
HELICOBACTER PYLORI INFECTION AND THE DEVELOPMENT OF GASTRIC CANCER NAOMI UEMURA, M.D., SHIRO OKAMOTO, M.D., SOICHIRO YAMAMOTO, M.D., NOBUTOSHI MATSUMURA, M.D., SHUJI YAMAGUCHI, M.D., MICHIO YAMAKIDO,
More informationThe Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma
The Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma PRESENTER: Dr. Md. Khalilur Rahman Student of M.D.(Internal Medicine) Sylhet MAG Osmani Medical College Gastric Cancer- ranked
More informationNew developments in pathogenesis, gastric cancer. Matthias Ebert. II. Medizinische Klinik Klinikum rechts der Isar TU München
New developments in pathogenesis, diagnosis, therapy and prevention of gastric cancer Matthias Ebert II. Medizinische Klinik Klinikum rechts der Isar TU München Gastric Cancer Pathogenesis Diagnosis Treatment
More informationHigh Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up
Gut and Liver, Vol. 7, No. 2, March 2013, pp. 175-181 ORiginal Article High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up Hyuk Yoon, Sang Gyun Kim, Hyun Chae Jung, and In Sung Song
More informationDetermination of the Frequency of Different Blood Types in Patients with Stomach Cancer Referring to Shahid Beheshti Hospital during
Brief Report J Babol Univ Med Sci Vol 17, Issu 8; Aug 2015. P:63-67 Determination of the Frequency of Different Blood Types in Patients with Stomach Cancer Referring to Shahid Beheshti Hospital during
More informationFactors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era
ORIGINAL ARTICLE Clin Endosc 2018;51:478-484 https://doi.org/10.5946/ce.2018.006 Print ISSN 2234-2400 On-line ISSN 2234-2443 Open Access Factors Affecting Endoscopic Curative Resection of Gastric Cancer
More informationGastric atrophy: use of OLGA staging system in practice
Gastroenterology and Hepatology From Bed to Bench. 2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Gastric atrophy: use of OLGA staging system in practice Mahsa
More informationPerigastric Lymph Node Metastasis from Papillary Thyroid Carcinoma in a Patient with Early Gastric Cancer: The First Case Report
J Gastric Cancer 2014;14(3):215-219 http://dx.doi.org/10.5230/jgc.2014.14.3.215 Perigastric Lymph Node Metastasis from Papillary Thyroid Carcinoma in a Patient with Early Gastric Cancer: The First Gui-Ae
More informationSAM PROVIDER TOOLKIT
THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org The American Board of Pathology (ABP) approves educational
More informationExpression of the GLUT1 and p53 Protein in Atypical Mucosal Lesions Obtained from Gastric Biopsy Specimens
The Korean Journal of Pathology 2006; 40: 32-8 Expression of the GLUT1 and p53 Protein in Atypical Mucosal Lesions Obtained from Gastric Biopsy Specimens In Gu Do Youn Wha Kim Yong-Koo Park Department
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationGastric Polyps. Bible class
Gastric Polyps Bible class 29.08.2018 Starting my training in gastroenterology, some decades ago, my first chief always told me that colonoscopy may seem technically more challenging but gastroscopy has
More informationAcid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe
Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationClinicopathologic Analysis of Lymphocytic Gastritis
The Korean Journal of Pathology 2007; 41: 289-95 Clinicopathologic Analysis of Lymphocytic Gastritis Jeong Eun Hwang Young Ok Hong Dong Eun Song Se Jin Jang Eunsil Yu Department of Pathology, University
More informationÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ
ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ 205 206 ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ EPITHELIAL CELL TURNOVER IN NON-DYSPLASTIC GASTRIC MUCOSA ADJACENT TO EARLY AND
More informationCase Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy
Volume 2012, Article ID 368160, 4 pages doi:10.1155/2012/368160 Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy Kazuyoshi Yagi,
More informationGastrointestinal Tract Cancer
Gastrointestinal Tract Cancer Tumors of the Stomach Gastric adenocarcinoma Incidence and Epidemiology Incidence mortality rates USA High incidence: Japan, China, Chile, Ireland risk lower socioeconomic
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationSerotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum
2012 66 4 351 356 Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum a b* c c c a a b d a c b d 352 Ohara et al. received remedies at another hospital. Hematemesis then recurred
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationEarly and long term outcomes of endoscopic submucosal dissection for early gastric cancer in a large patient series
594 Early and long term outcomes of endoscopic submucosal dissection for early gastric cancer in a large patient series KEN OHNITA 1, HAJIME ISOMOTO 1, SABURO SHIKUWA 2, HIROYUKI YAJIMA 1, HITOMI MINAMI
More informationHelicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
pissn : 2093-582X, eissn : 2093-5641 J Gastric Cancer 2015;15(4):246-255 http://dx.doi.org/10.5230/jgc.2015.15.4.246 Original Article Helicobacter pylori Eradication Reduces the Metachronous Recurrence
More informationmalignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen
Plan Incidental finding of a malignant polyp 1. What is a polyp malignant? 2. Role of the pathologist and the endoscopist 3. Quantitative and qualitative risk assessment 4. How to decide what to do? Hubert
More informationGastric Extremely Well-Diferentiated Intestinal-Type Adenocarcinoma: A Challenging Lesion to Achieve Complete Endoscopic Resection
Gastric Extremely Well-Diferentiated Intestinal-Type Adenocarcinoma: A Challenging Lesion to Achieve Complete Endoscopic Resection The Harvard community has made this article openly available. Please share
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF GASTRIC CARCINOMAS SUMMARY Scientific Coordinator: Univ. Prof. Dr. SIMIONESCU CRISTIANA EUGENIA
More informationMaastricht Ⅴ /Florence
2016 21 10 577 Maastricht Ⅴ /Florence 200001 2015 10 8 9 Maastricht V 1 / 2 3 4 / 5 Maastricht Ⅴ Interpretation of Management of Helicobacter pylori Infection the Maastricht Ⅴ / Florence Consensus Report
More informationCorrelation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori
ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.
More informationRisk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment
pissn : 293-582X, eissn : 293-5641 J Gastric Cancer 216;16(4):215-22 https://doi.org/1.523/jgc.216.16.4.215 Original Article Risk Factors and Tumor Recurrence in pt1nm Gastric Cancer after Surgical Treatment
More informationOesophagus and Stomach update dysplasia and early cancer
Oesophagus and Stomach update dysplasia and early cancer Dr Tim Bracey STR teaching 13/4/16 Please check pathkids.com for previous talks One of the biggest units in the country (100 major resections per
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,
More informationEndoscopic Corner CASE 1. Sirimontaporn N Klaikaew N Imraporn B Rerknimitr R
Endoscopic Corner Sirimontaporn N, et al. THAI J GASTROENTEROL 2010 Vol. 11 No. 3 Sept. - Dec. 2010 171 Sirimontaporn N Klaikaew N Imraporn B Rerknimitr R CASE 1 A 47- year-old female presented to the
More information위 ESD 후내시경소견 성균관대학교의과대학내과이준행
위 ESD 후내시경소견 성균관대학교의과대학내과이준행 문제의식 위궤양, 조기위암, 진행위암의내시경소견은배운다. 위암수술후소견은가끔배운다. 위암내시경시술후소견은배운적이없다. 관찰과조직검사에대한가이드라인이없다. ESD 후정상내시경소견 성균관대학교의과대학내과이준행 처음의뢰되었을때의사진 ESD M/D, 18mm, LP, RM (-), L/V (-) 추적내시경소견 2
More informationClinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer
Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer HITOSHI OJIMA 1, KEN-ICHIRO ARAKI 1, TOSHIHIDE KATO 1, KAORI
More informationSUMMARY INTRODUCTION. Accepted for publication 22 January 2003
Aliment Pharmacol Ther 23; 17: 1535 1543. doi: 1.146/j.1365-236.23.1587.x Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and
More informationRole of Helicobacter pylori Infection and Chronic Inflammation in Gastric Cancer in the Cardia
Original Article Japanese Journal of Clinical Oncology Advance Access published June 19, 2007 Jpn J Clin Oncol doi:10.1093/jjco/hym029 Role of Helicobacter pylori Infection and Chronic Inflammation in
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description
More informationB Breast cancer, managing risk of lobular, in hereditary diffuse gastric cancer, 51
Index Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, gastric. See also Gastric cancer. D2 nodal dissection for 57 70 Adjuvant therapy, for gastric cancer, impact of D2 dissection
More informationThe Nobel Prize in Physiology or Medicine for 2005
The Nobel Prize in Physiology or Medicine for 2005 jointly to Barry J. Marshall and J. Robin Warren for their discovery of "the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationHistopathological Characteristics of Atrophic Gastritis in Adult Population
Journal of Pharmacy and Pharmacology 3 (2015) 133-138 doi: 10.17265/2328-2150/2015.03.004 D DAVID PUBLISHING Histopathological Characteristics of Atrophic Gastritis in Adult Population Marija Milićević,
More informationLymph node metastasis risk according to the depth of invasion in early gastric cancers confined to the mucosal layer
Gastric Cancer (2016) 19:860 868 DOI 10.1007/s10120-015-0535-7 ORIGINAL ARTICLE Lymph node metastasis risk according to the depth of invasion in early gastric cancers confined to the mucosal layer Young-Il
More informationGastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath
Gastrointestinal pathology 2018 lecture 2 Dr Heyam Awad FRCPath Eosinophilic esophagitis Incidence of eosinophilic gastritis is increasing. Symptoms: food impaction and dysphagia. Histology: infiltration
More informationTriple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Chang et al. BMC Gastroenterology (2017) 17:16 DOI 10.1186/s12876-017-0579-8 RESEARCH ARTICLE Open Access Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication Ji
More informationStudy of expression of P53 in Gastric Carcinoma As a prognostic indicator
Original Research Article Study of expression of P53 in Gastric Carcinoma As a prognostic indicator K. Padma Malini 1*, Srivani 2, O. Shravan Kumar 3 1 Assistant Professor, 2 Associate Professor, 3 Professor
More informationUrea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013
MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index
More informationComparative study of invasive methods for diagnosis of Helicobacter pylori in humans
ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationUpdate on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada
Update on the pathological classification of gastritis Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada CLASSIFICATION GASTRITIS GASTROPATHY 1. Acute 2. Chronic 3. Uncommon
More informationRisk factors for non-curative resection of early gastric neoplasms with endoscopic submucosal dissection: Analysis of 1,123 lesions
EXPERIMENTAL AND THERAPEUTIC MEDICINE 9: 1209-1214, 2015 Risk factors for non-curative resection of early gastric neoplasms with endoscopic submucosal dissection: Analysis of 1,123 lesions TATSUYA TOYOKAWA
More informationPathology of the oesophagus and the stomach. Neil A Shepherd Gloucester, UK. Bristol Pathology 1 st Year Training School, The layers of the GI tract
Pathology of the oesophagus and the stomach Neil A Shepherd Gloucester, UK Bristol Pathology 1 st Year Training School, The layers of the GI tract 1 Some facts about Histopathology and the upper GI tract
More informationGastric adenocarcinoma of the
Comment From the Editors Spasmolytic Polypeptide- Expressing Metaplasia and Intestinal Metaplasia: Time for Reevaluation of Metaplasias and the Origins of Gastric Cancer Gastric adenocarcinoma of the intestinal
More informationPrinciples of diagnosis, work-up and therapy The Gastroenterologist s role
Principles of diagnosis, work-up and therapy The Gastroenterologist s role Dr. Christos G. Toumpanakis MD PhD FRCP Consultant in Gastroenterology/Neuroendocrine Tumours Hon. Senior Lecturer University
More information